Bedoradrine-d6
CAS: 194785-19-8
Ref. 3D-UHA78519
| 5mg | A consultar | ||
| 10mg | A consultar | ||
| 25mg | A consultar | ||
| 50mg | A consultar |
Informação sobre produto
- Acetamide, N,N-dimethyl-2-[[(7S)-5,6,7,8-tetrahydro-7-[[(2R)-2-hydroxy-2-[4-hydroxy-3-(2-hydroxyethyl)phenyl]ethyl]amino]-2-naphthalenyl]oxy]-
- Acetamide, N,N-dimethyl-2-[[5,6,7,8-tetrahydro-7-[[2-hydroxy-2-[4-hydroxy-3-(2-hydroxyethyl)phenyl]ethyl]amino]-2-naphthalenyl]oxy]-, [R-(R*,S*)]-
- N,N-Dimethyl-2-[[(7S)-5,6,7,8-tetrahydro-7-[[(2R)-2-hydroxy-2-[4-hydroxy-3-(2-hydroxyethyl)phenyl]ethyl]amino]-2-naphthalenyl]oxy]acetamide
Bedoradrine-d6 is an analog of bedoradrine that acts as a potent inhibitor of kinases. It has been shown to inhibit the activity of cyclin-dependent kinases, which play a critical role in the regulation of cell division and proliferation. Bedoradrine-d6 has demonstrated promising anticancer effects in cancer cells, inducing apoptosis and inhibiting tumor growth. This protein kinase inhibitor has been extensively studied in Chinese hamster ovary cells and human cancer cell lines, showing significant medicinal potential for cancer treatment. As a kinase inhibitor, bedoradrine-d6 represents a promising therapeutic option for cancer patients who require targeted therapy to combat their disease.
Propriedades químicas
Consulta técnica sobre: 3D-UHA78519 Bedoradrine-d6
Se desejar solicitar um orçamento ou fazer uma encomenda, por favor, adicione os produtos ao seu carrinho e depois solicite um orçamento ou encomenda a partir do carrinho. É mais rápido, mais barato e poderá beneficiar-se dos descontos e outras vantagens disponíveis.
